Harmony Biosciences Holdings, Inc. Quarterly Operating Income (Loss) in USD from Q3 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Harmony Biosciences Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q2 2024.
  • Harmony Biosciences Holdings, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was $21.4M, a 54.5% decline year-over-year.
  • Harmony Biosciences Holdings, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was $178M, a 21.3% increase year-over-year.
  • Harmony Biosciences Holdings, Inc. annual Operating Income (Loss) for 2023 was $192M, a 59.8% increase from 2022.
  • Harmony Biosciences Holdings, Inc. annual Operating Income (Loss) for 2022 was $120M, a 37.3% increase from 2021.
  • Harmony Biosciences Holdings, Inc. annual Operating Income (Loss) for 2021 was $87.5M, a 415% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $178M $21.4M -$25.5M -54.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $204M $52M +$11.6M +28.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $192M $40.2M -$7.42M -15.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $199M $64.5M +$52.6M +442% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $147M $46.9M +$13.8M +41.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $133M $40.4M +$12.9M +46.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $120M $47.6M +$19M +66.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $101M $11.9M -$9.15M -43.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $110M $33.1M +$9.8M +42.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $101M $27.6M +$13M +89.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $87.5M $28.6M +$19.7M +221% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $67.8M $21.1M +$10.7M +103% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $57.1M $23.3M +$16M +219% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $41.1M $14.5M +$24.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $17M $8.91M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $10.4M +$40.2M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $7.31M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$9.61M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 -$29.8M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.